Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Risk Factors and Biomarkers for Post-tuberculosis Lung Damage — Stella

Home/Pulmonary TB/Risk Factors and Biomarkers for Post-tuberculosis Lung Damage

View on ClinicalTrials.gov

Recruiting

Back to Pulmonary TB trials

Risk Factors and Biomarkers for Post-tuberculosis Lung Damage

Trial locations(2 sites)

China

Peking University Third Hospital, Beijing

Beijing Geriatric Hospital, Beijing

Key details

Sponsor

Peking University Third Hospital

Collaborators

Beijing Geriatric Hospital

Enrollment target

~400 participants

Started

January 2022

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

25 Years – 60 Years

Sex

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Male only

Last updated June 2022